Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards

Bayer bolsters presence in Finland with €250 million investment

By Brian Buntz | June 11, 2021

BayerBayer (ETR:BAYN) is pumping cash into its operations in Turku, a city on the southwest coast of Finland. 

The company is at once modernizing its current operations there while also constructing a new pharmaceutical plant.  

Bayer notes that the new facility will make extensive use of automation and robotics. 

Bayer first built the existing Turku plant in the 1960s. 

In all, the company is investing some €250 million in its Turku operations. Bayer describes Turku as “the world’s contraceptive capital.”

In 2020, the company announced a €35 million investment in its Turku production supply center, which produces polymer-based contraceptive devices. 

According to Miriam Holstein, CEO of Bayer Nordic, the Turku plants will play a role in providing one hundred million women in developing countries with access to contraceptives by 2030.

The company aims to finish the construction of the new plant by 2025. 

Bayer notes that Turku is the company’s international center for producing polymer-based pharmaceuticals and long-acting contraceptives.

The company sells a range of contraceptives, including birth control pills and contraceptive devices. It stopped selling the Essure for female sterilization device on Dec. 31, 2018, after some women experienced severe side effects from the device.

The company is also partnering with the U.S. biotech Daré Bioscience to develop a silicone ring that releases ferrous gluconate to impede sperm motility.

Last year, Bayer announced that it had a 30-year-plan to expand a biologics facility in Berkeley, Calif. 

The plant makes anticoagulant drugs for people with hemophilia. 

Tell Us What You Think! Cancel reply

Related Articles Read More >

Beckman Coulter
Beckman Coulter Life Sciences names Suzanne Foster as president 
Comau
Comau launches cleanroom-classified high-speed industrial robot
Purdue University
Purdue University launches institute for advanced manufacturing of pharmaceuticals
sustainability
How pharma can optimize for right-the-first-time drug manufacturing and sustainability

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Pharmaceutical Processing news in a minute?

We Deliver!
Pharmaceutical Processing Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Pharmaceutical Processing World
  • Subscribe to Our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards